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Summary: Tris and HEPES were systematically compared äs buffers for the enzymatic assay of L-carnitine.
The deproteinization methods preceding the assay were also compared. The following conclusions were drawn.
1. Both Tris and HEPES act on the catalytic site of the enzyme, acetylCoA: carnitine O-acetyltransferase
(EC 2.3.1.7), which is used for the conversion of L-carnitine to acetylcarnitine. HEPES is a competitive
inhibitor, and no acetylated product of HEPES is formed. In the presence of Tris a limited amount of
acetylTris is formed, and an appropriate blank corrects for this effect.
2. The incubation time of the assay is strongly influenced by the preceding deproteinization method. The
enzyme is influenced by inorganic salt, which acts äs a competitive inhibitor.
3. If Tris is used in place of HEPES in end-point assays, optimal conditions and shorter assay times are
achieved with less enzyme and less acetylCoA, provided more elaborate deproteinization methods are used.
4. The HEPES System is more costly, but preferable for the determination of both total and free L-carnitine
in combination with a matched deproteinization method.
Introduction
L-Carnitine functions primarily in the transport of
fatty acids across the mitochondrial membrane (1). It
is present either free or esterified (1). Subnorrnal con-
centrations in serum may result from a primary cause
(2), or can be secondary to pathological conditions
such äs kidney disease and dialysis (3, 4), parenteral
nutrition (5) pr inborn errors of metabolism (6). These
conditions affect the metabolic processing of fatty
acids. L-Carnitine is easily esterified in vitro, and this
*) Enzyme
AcetylCoA : carnitine O-äcetyltransferase (EC 2.3.1.7)
2) Abbreviatiorts
CoASH
EDTA
HEPES
MOPS
Tris
coenzyme A
ethylenediaminetetra-acetic acid
N-2-hydroxyethylpiperazine-N'-ethanesulphonic
acid/iu
3-(N-morpholino)propanesulphonic acid
Tris(hydroxymethyl)aminomethane
process can be exploited for measuring both free and
total serum L-carnitine. Several methods have been
described for the measurement of L-carnitine in serum
or plasma. Marquis & Fritz developed an enzymatic
assay (7): acetylCoA: carnitine O-acetyltransferase
(EC 2.3.1.7)1) catalyses the formation of acetylcarni-
tine and CoASH2) from L-carnitine and acetylCoA.
CoASH2) reacts with 5,5/-dithiobis-(2-nitrobenzoic
acid) to form 5-thio-2-nitrobenzoate, which can be
measured at 412 nm. Deproteinization is necessary to
avoid non-specificreduction of 5,5'-dithiobis-(2-nitro-
benzoic acid). The procedure has been variously mod-
ified with respect to deproteinization, hydrolysis of
esterified L-carnitine, and the nature of the buffer
(8-10).
We compared different assay conditions, and we stud-
ied the influence of deproteinization, hydrolysis, and
buffer on the performance of the assay.
J. Clin. Chem. Clin, Biochem. / Vol. 27,1989 / No. 12
968 Tegelaers et al.: Enzymatic assay of carnitine in serum
Materials and Methods
Mater ia ls
AcetylCoA: carnitine O-acetyltransferase (EC 2.3.1.7), /XL-ace-
tylcarnitine and acetylCoA were purchased from Boehringer,
Mannheim (FRG); ,-carnitine and 5,5'-dithiobis-(2-nitroben-
zoic acid) were from Sigma, St. Louis, MO 63178 (USA); other
chemicals of analytical grade were obtained from Merck,
Darmstadt (FRG).
Methods
For deproteinization of serum wifhout subsequent hydrolysis of
L-carnitine esters the following methods were used:
1: the perchloric acid method
Serum (2.0 ml) was mixed with 0.5 ml (140 g/l) of cold HC1O4.
After 30 min at 4 °C the mixture was centrifuged for 5 min at
10000g. To 1.0 ml of supernatant cold 0.5 mpl/1 MOPS2) in
2.0 mol/1 KOH or solid KHCO3 was added until the pH was
between 7 and 8. After 30 min at 4 °C the mixture was centri-
fuged for 5 min at 10 000 g. The clear supernatant was used for
the assay.
2: the trichloroacetic acid method
Serum (2.0 ml) was mixed with 0.5 ml (200 g/l) of cold trichlo-
roacetic acid. After 30 min at 4 °C the mixture was centrifuged
for 5 min at 10000 g. To the supernatant 2.0 mol/1 NaOH was
added until the pH was between 7 and 8, or the supernatant
was extracted with 7.5 ml of diethyl ether to remove trichlo-
roacetic acid. This was repeated twice until the pH was between
6 and 7. Remaining traces of diethyl ether were removed by a
gentle nitrogen stream.
3: the ZnSO4-Ba(OH)2 method
This method was performed according to Seccombe et al. (8).
4: the heat denaturation and freeze-thawing method
This method was performed according to Rodriguez-Segade et
al. (9).
In all methods a Cryofuge 5000 (Heraeus Christ, Osterode/
Harz, FRG) was used for centrifugation.
Deproteinization with subsequent hydrolysis of L-carnitine esters
Serum (2.0 ml) was mixed with 0.5 ml (140 g/l) of cold HC1O4.
After 30 min at 4 °C and subsequent centrifugation for 5 min
at 10000g, 0.2 ml of KOH (5 mol/1) was added to 1.5 ml of
the supernatant. After 10 min at 4 °C, the sample was centri-
fuged for 5 min at 10000 g and the supernatant was incubated
at 80 °C for 60 min. Cold HC1O4 was added until the pH was
<7. After centrifugation for 10 min at 10000g, solid KHCO3
was added to the supernatant until the pH was between 7 and
8. After centrifugation, the clear supernatant was used for the
assay.
Assays
For the enzymatic assay of L-carnitine two methods were
compared. Thefirst method was according to the procedure äs
described by Wieland et al. (11). To 1.0 ml of deproteinized
serum or Standard solution, 0.9 ml reagent was added. The
reaction was started with 0.1 ml of acetylCoA: carnitine O-
acetyltransferase (0.25 g/l, 80 kU/g). Final reagent concentra-
tions are summarized in table 1.
The second method was äs described by Pearson et al. (12). To
1.0 ml of deproteinized serum or Standard solution, 1.0 ml of
reagent was added. The reaction was started by the addition of
10 of acetylCoA : carnitine O-acetyltransferase (l g/l, 80
kU/g). Final reagent concentrations are summarized in table 1.
Tab. l. Final reagent concentrations in commonly used enzy-
matic L-carnitine assays.
Reagent
HEPES KOH pH 7.5
Tris-HCl pH 7.8
5,5'-Dithiobis-(2-
nitrobenzoic acid
EDTA
AcetylCoA
AcetylCoA : carnitine^
O-acetyltransferase
Tris-buffered
assay
(Pearson et al.)
100 mmol/1
1.25 mmol/1
0.20 mmol/1
0.8 U
HEPES-buffered
assay
(Wieland 'et al.)
36 mmol/1
0.200 mmol/1
0.72 mmol/1
0.55 mmol/1
2 U
Standards were made by dilution of a L-cärnitiiie stock solution
(l mmol/1) with isotonic saline. To investigate the effect of satt,
the stock solution was diluted with Solutions of NaCl, K2SO4
or sucrose to the desired concentration and conductivity c. q.
osmolality. For the reagent blank, iso-osmotic saline Solutions
were used.
Absorbances (A412nm) of the reaction mixtures were measured
continuously at 25 °C for 5 to 15 min on a Perkin Eimer 554
spectrophotometer (Perkin Eimer Corp., Norwaik CT 06856,
USA). The molar lineic absprbance of 5-thio-2-nitrobenzoate
is 1360 m2/mol (13). Osmolalities were measured on a Vapor
Pressure Osmometer (Wescor Inc., Logan, Utah 84321 > USA),
Conductivities were measured on a Radiometer DCM 83 Con-
ductivity Meter (Radiometer, Copenhagen, Denmark).
Resülts
The time required for complete conversion of L-car-
nitine to acetylcarnitine is dependent upon the con-
ditions of the assay. In figure l, lines a, b, g and h
show the effect of deproteinization methods on the
reaction times in the assay System according to Pear-
son et äl. Similar results were obtained with the
HEPES-buffered assay according to Wieland et äl.
(lines c, d, f). The shortest reaction times were ob-
tained with a Tris2)-buffered assay.
The effect of the reagent buffer
The ability of acetylCoA: carnitine Ö-acetyltrans-
ferase1) to acetylate Tris is shown in figure 2. Assay
conditions were according to Pearson et al,, but L-
carnitine was omitted and the concentration of Tris
in the assay was varied. NaCl was added to obtain
the same conductivity in all assays. Tris is acetylated
by the enzyme, the Km of the reaction being 175
mmol/1 and the Fmax 1.3 nmol/min. No acetylation of
HEPES2) was found. Nevertheless, figure 3 shows a
competitive inhibitory effect of HEPES on the ace-
tylation of L-carnitine in the Tris-buffered system
according to Pearson et al. HEPES influences the
acetylation of Tris in a similar way (not shown).
Similar effects are obtained when another Goocfs
buffer, MOPS2), is used.
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Fig. 1
T 0.05
{ units
2min
Reoction time of assay
Reaction times of L-carnitine assays. Different assay
conditions (bufier type, enzyme and acetylCoA concen-
tration) and diflferent deproteinization methods were
used.
line a: Tris-buffered assay according to Pearson et al.
(12); aqueous L-carnitine Standard (no deproteiniza-
tion).
line b: Tris-buffered assay according to Pearson et al.
(12); trichloroacetic acid deproteinization with ether
extraction neutralization.
line c: HEPES-buffered assay according to Wieland et
al. (11); HC1O4 deproteinization with KHCO3 neutral-
ization.
line d: HEPES-buffered assay according to Wieland et
al. (11); trichloroacetic acid deproteinization with ether
extraction neutralization.
line e: Tris-bufFered assay according to Pearson et ai.
(12), but enzyme and acetylCoA concentration s in the
HEPES-buffered assay according to Wieland & al. (11);
HC1O4 deproteinization with KHCO3 neutralization.
line f: HEPES-buffered assay according to Wieland et
al. (11); aqueous L-carnitine Standard (no deproteini-
zation).
line g: Tris-buffered assay according to Pearson et al.
(12); HC1O4 deproteinization with KHCO3 neutraliza-
tion.
line h: Tris-buffered assay according to Pearson et al.
(12); HC1O4 deproteinization with MOPS-KOH neu-
tralization,
H- 2
OU-
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Fig. 2. Lineweaver-Burk plot of acetylCoA: carnitine O-acetyl-
transferase.
The concentration of Tris was varied; the osmolality of
the 'assay was kept constant at 254 mosmol/kg with
NaCl. Further conditions were s described in Materials
and Methods.
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1
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ofFig. 3. The effect of HEPES on the kinetics
acetylCoA: carnitine O-acetyltransferase.
HEPES was added to the Tris-buffered assay with var-
iable L-carnitine concentrations: β —o: no addition;
o —o: addition 100 mmol/1. Conditions were s de-
scribed in Materials and Methods.
The effect of deproteinization
The effect of salt on the kinetics of acetylCoA:
carnitine O-acetyltransferase is shown in figure 4.
20
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Fig. 4. The effect of sodium Chloride on the kinetics of
acetylCoA: carnitine O-acetyttransferase.
Different concentrations of NaCl were added to the
Tris-buffered assay. Conditions were s described in
Materials and Methods, exept for o — o: here, 50 mmol/1
Tris was present in the assay instead of 100 mmol/1.
After complete conversion of L-carnitine to acetylc r-
nitine, osmolalities and conductivities were measured.
Line
0-0
Δ-Δ
fl-B
O — O
α- α
NaCl in
assay
mmol/1
—100
200
300
Osmolality
mosmol/kg
159
198
295
373
513
Conductivity
mS/cm
3.9
6.9
11.0
17.4
23.7
J. Clin. Chem. Clin. Biochem?. / Vol. 27,1989 / No. 12
970 Tegelaers et al.: Enzymatic assay of carnitine in serum
12.5
10.0
i i7·5
1 ^i r n5.0
τ— .^
2.5
0
Tab. 2. Osmolality and conductivity in the assay mixtures after
deproteinization according to different methods.
:
" ./
/ Method
/ :
K .'
1 1 1 ' 1 ^ r
-5 0 5 10 15 20 25 J*
1 Γ 1 1 *[
[Z- Carnitine] lmmol / l j 0!o l
Trichloroacetic acid;
ether extraction
Trichloroacetic acid;
NaOH neutralization
HCiO4; MOPS-KOH neu-
tralization
HC1O4; KHCO3 neu-
tralization
ZnSO4 - Ba(OH)2
Heat-Freeze-Thaw
Non-deproteinized serum
Water
Osmolality
mosmol/kg
330
430
 ; ,
375
415
210
300
300
200
Conductivity
mS/cm
11.4
14.6
13.7
14.1
7.4
11.0
11.1
7.0
Fig. 5. The effect of potassium sulphate and sodium chloride
on the kinetics of acetylCoA: carnitine O-acetyltrans-
ferase.
The Tris-buffered assay was used. Conditions were s
described in Materials and Methods.
o-o K2SO4 140 mmol/1; o-o NaCl 200 mmol/1.
After complete conversion of L-carnitine to acetylcar-
nitine, osmolalities and conductivities were: (o —o) 355
mosmol/kg and 16.4 mS/cm; (a — o) 360 mosmol/kg
and 15.8 mS/cm.
1—6: serum was deproteinized s described in Materials and
Methods, and l ml of superaatant was added to l ml of assay
mixture. Final concentrations were s described in Materials
and Methods, according to the method of Pearson et al. After
complete conversion of Ζ,-carnitine to acetylcarnitine, osmolal-
ities and conductivities were measured.
7 —8: s a control, l ml of non-deproteimzed serum (7) or l ml
of water (8) was added to the assay reagent instead of depro-
teinized serum.
Using aqueous L-carnitine Standards, Lineweaver-
Burk plots were made at different NaCl concentra-
tions. The lowest Km is seen under the conditions
described by Pearson et al. Increasing the concentra-
tion of NaCl to 300 mmol/1 results in an increase of
the Km to 435 μτηοΐ/l. No effect on the Fmax was
observed. To exclude an effect of NaCl itself on the
enzyme, K2SO4 (140 mmol/1) was added instead of
NaCl (200 mmol/1). At identical osmolalities and con-
ductivities no significant differences were observed
(fig. 5) suggesting that the enzyme was influenced by
the ionic strength in the assay. This was confirmed
by the observation (not shown) that no increase in
JKm was observed when sucrose was added to the assay,
i.e. when the osmolality but not the ionic strength
was increased.
Similar results were obtained with the HEPES-buff-
ered assay according to Wieland et al. (not shown).
Deproteinization methods affect the conductivities
and osmolalities of the Tris-buffered assays according
to Pearson et al. (tab. 2). This is reflected in the time
for the complete enzymatic conversion of L-carnitine
to acetylcarnitine (fig. l, line a, b, g, h). Similar effects
are obtained with the HEPES-buffered assay accord-
ing to Wieland et al., in which the osmolality is 106
mosmol/kg after the addition of an aqueous L-car-
nitine Standard (fig. l, line f). After the addition of a
serum that had been deproteinized with HC1O4 and
neutralized with KHCO3, the osmolality was 331 mos-
mol/kg (fig. l, linec).
The combination of reagent buffer and de-
proteinization
A comparison of results obtained with the HEPES-
buffered assay of Wieland et al. and with the Tris-
buffered assay of Pearson et al. is shown in table 3.
Omission of a reagent blank in the latter assay results
in a minor increase of the measured value. In table 3
the trichloroacetic acid method with subsequent ether
extraction is used for deproteinization. In table 3b the
Tab. 3. Intra-assay Variation of L-carnitine in two pqol sera,
s measured with enzymatic assays containing HEPES
or Tris buffer.
Pool serum l
mean CV
μπιοΐ/ΐ %
Pool serum 2
mean CV
μηιοΐ/ΐ %
a: Trichloroacetic acid; ether extraction
1: HEPES-buffered assay: 35.8 5.1 52.1 4.7
2: Tris-buffered assay,
including blank: 35.0 3.1 51.5 2.1
without blank: 36.2 3.0 52.7 2.2
b: HC104; KHCO3
1: HEPES-buffered assay:
2: Tris-buffered assay,
including blank:
without blank:
*
35.1
36.1
38.0
3.9
10.2
9.9
51.9
53.0
54.1
2.8
7.6
8.1
Assays were s described in Materials and Methods (n = 15).
Sera were deproteinized, either by the trichloroacetic acid
method with subsequent neutralization by ether extraction (a),
or by the perchloric acid method with subsequent KHCO3
neutralization (b). For the reagent blank, NaCl was added
instead of serum to obtain the same assay osmolality.
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perchloric acid method with subsequent KHCO3 neu-
tralization is used. By using this method of depro-
teinization, carnitine esters are hydrolysed and the
recoveries of added L-carnitine and acetylcarnitine
are between 89% and 103%. Moreover, dilution is
minimal and no extra salt is introduced, compared
with the non-hydrolysed sample (osmolalities: 428
± 38 mosmol/1 vs. 431 ± 32 mosmol/1; n = 5).
Discussion
Several enzymatic methods, both manual and auto-
mated, for the determination of L-carnitine in serum
or plasma have been described (7 — 10, 14, 15). Most
of them are colorimetric assays. Their principal dif-
ferences are in the buffer and in the deproteinization
method that precedes the assay.
The effect of reagent buffer
Christiansen & Bremer claim that Tris functions s an
acetyl-group receptor (16). HEPES is not acetylated
and is therefore recommended (16). These results are
often referred to by other HEPES-using authors, and
they are even used to explain grossly differing results
(17).
We studied the acetylation of Tris in the assay System
of Pearson et al. and quantitated the amount of ace-
tylated product by the formation of 5-thio-2-riiitro-
benzoate. When the concentration of Tris in the assay
was 100 mmol/1, about 2 μπιοΐ/ΐ of acetylTris was
formed in a reaction time of 5 min, whereas reference
values of free L-carnitine r nge from 30 to 70 μιηοΐ/ΐ.
Longer incubation times lead to an increase in the
formation of acetylTris, but a reagent blank corrects
for this effect (tab. 3). Although the amount of
acetylTris that is formed depends upon the assay, the
formation of this compound should not be held re-
sponsible for the wide Variation of results, s proposed
by F rst & Gl ggler (17).
It is stated that HEPES is not acetylated and that it
therefore dpes not interfere with the assay (16). This
is only partially true. We have shown that HEPES
functions s a competitive inhibitor of the enzyme.
The same effect is observed with another GoocTs
buffer, MOPS. The catalytic centre of the enzyme
must have affinity for these buffers, despite the fact
that there is no detectable formation of an acetylated
product. This could explain why higher concentra-
tions of acetylCoA: carnitine O-acetyltransferase and
acetylCoA are needed in the HEPES-buffered System
according to Wieland et al. to obtain acceptable re-
action times.
The effect of deproteinization
The efficiency of the assay is not only dependent upon
the choice of the buffer. It should also be recognized
that the efficiency is influenced by the deproteiniza-
tion method preceding the assay. It is clear that these
methods introduce a variable amount of salt (tab. 2).
Even serum electrolytes affect the ionic strength. The
ZnSO4-Ba(OH)2 method (8) seems more appropriate
for keeping the ionic strength low, but this is due to
dilution, thus decreasing the sensitivity of the assay.
Amicon filter cones (8, 10), or the heat denaturation
of freeze-thawing method (9) and the trichloroacetic
acid method with subsequent ether extraction (18)
have the least effect, but they are either expensive
(Amicon) or elaborate.
The negative effect of salt on the properties of
acetylCoA: carnitine O-acetyltransferase is clearly
demonstrated in figure 4. The effect is independent
of the nature of the salt (fig. 5) and solely due to the
ionic strength of the assay. Addition of sucrose has
no effect at all. Salts act s if they were competitive
inhibitors. This could be due to masking of charges
on molecules (Debye-H ckel effect). Increased
amounts of acetylCoA: carnitine O-acetyltransferase
and acetylCoA are required in the assay to obtain
acceptable reaction times (fig. l, line e, g). Thus the
choice of the buffer should be combined with the
choice of the deproteinization method.
The combination of buffer and deproteini-
zation
One can use the Tris-buffered assay according to
Pearson et al. A reagent blank is necessary, s well s
a deproteinization method that introduced a mini-
mum amount of salt, e. g. heat denaturation and
freeze thawing or trichloroacetic acid with subsequent
ether extraction. With the latter method, the overall
Performance is similar to the HEPES-buffered assay
(tab. 3). If a deproteinization method is used that
introduces more salt, then more acetylCoA and more
acetylCoA: carnitine O-acetyltransferase are required
in the assay for acceptable results, thereby depriving
the Tris-buffered method of its only advantage (fig.
l, line e, f). A disadvantage of ether extraction is that
long chain acylcarnitines may also be extracted, so
that the method is not suitable for the determination
of total L-carnitine.
The second possibility is the use of the HEPES-buff-
ered assay according to Wieland et al. in combination
with perchloric acid deproteinization with subsequent
KHCO3 neutralization (fig. l, line c). Due to tlie
unfavourably low osmolality of the HEPES-buffered
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assay (±100 mosmol/kg), the reaction with an
aqueous L-carnitine Standard is very slow (flg. l, line
f). The addition of salt increases the osmolality of the
assay towards optimal values and decreases the re-
action time (fig. l, line c, d). This is in contrast to the
Tris-buffered assay. With an aqueous L-carnitine
Standard the osmolality is already in the optimal
ränge, so that additional salt increases the osmolality
away from optimal values, and the reaction time
increases (fig. l, line a, b, g). Also, concentrations of
acetylCoA and acetylCoA: carnitine O-acetyltransfer-
ase are higher in the HEPES-buffered assay. The
results from table 3 show that the preferred method
is the HEPES-buffered assay in combination with the
perchloric acid deproteinization with subsequent
KHCO3 neutralization. An advantage of this method
is the possibility of determining both free and acylated
L-carnitine. By using the proposed method for the
hydrolysis of esterified carnitine esters, the amount of
extra salt can be kept within the same limits äs those
in the unhydrolysed sample.
Thus we prefer methods that employ HEPES rather
than Tris, because the deproteinization method is
more convenient, and because it'fe possible to deter-
mine both total and free L-carnitine. Moreover, the
additional problem of the acetylation of Tris is
avoided.
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